mywealthgrid
Overview
Dashboard
My workspace
My PortfolioWatchlistsFollowingScreenersAlertsResearch
Discover
CompaniesSectorsIndicesMutual fundsInstitutional investorsCompareTrade trends
Market updates
ResultsAnnouncementsSearch filingsCalendarUpcoming listings
Sign in to save your work
Sign inSign up
Loading page…
SP

Sotac Pharmaceuticals Limited

NSE:SOTACSME
UnclassifiedUnclassified
₹90.1
0%1 Oct close
Mkt cap
—
Watch Alert Compare
OverviewChartPeersProfit & lossBalance sheetCash flowRatiosShareholdingF&ODocumentsEventsAnnouncementsNotes
ConsolidatedStandalone

Standalone figures

RatioMar 2025Mar 2026
Margins
Gross margin %29.6%30.9%
EBITDA margin %12.3%12.7%
EBIT margin %8.4%9.2%
PAT margin %7.7%6.8%
Working capital
Receivable days——
Inventory days85112
Payable days——
NWC days——
Leverage
Current ratio2.071.78
Debt to EBITDA——
Debt to equity——
Interest coverage6.54.9
Asset turnover0.730.76
Return ratios
Return on assets %5.6%5.2%
Return on capital employed %12.9%14.7%
Return on equity %——

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.